Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Biofrontera AG
  6. News
  7. Summary
    B8F   DE0006046113

BIOFRONTERA AG

(B8F)
  Report
Delayed Quote. Delayed Xetra - 01/26 11:36:09 am
1.35 EUR   +3.45%
01/25European ADRs Move Lower in Tuesday Trading
MT
01/21European ADRs Move Lower in Friday Trading
MT
01/20European ADRs Move Lower in Thursday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

European ADRs Nudge Higher in Wednesday Trading

12/08/2021 | 11:07am EST


ę MT Newswires 2021
All news about BIOFRONTERA AG
01/25European ADRs Move Lower in Tuesday Trading
MT
01/21European ADRs Move Lower in Friday Trading
MT
01/20European ADRs Move Lower in Thursday Trading
MT
01/13BIOFRONTERA : announces preliminary revenue figures for the full year 2021 - Form 6-K
PU
01/13Biofrontera AG Provides Preliminary Revenue Guidance for the Full Year Ending December ..
CI
01/13Biofrontera AG Announces Revenue Results for the Fourth Quarter of 2021
CI
01/07European ADRs Move Higher in Friday Trading
MT
01/05European ADRs Move Higher in Wednesday Trading
MT
01/03European ADRs Move Higher in Monday Trading
MT
2021Biofrontera Says Parent Company Cuts Holdings to Below 50%
MT
More news
Financials
Sales 2021 28,3 M 31,8 M 31,8 M
Net income 2021 -27,8 M -31,2 M -31,2 M
Net Debt 2021 - - -
P/E ratio 2021 -2,93x
Yield 2021 -
Capitalization 76,6 M 86,4 M 86,0 M
Capi. / Sales 2021 2,71x
Capi. / Sales 2022 1,87x
Nbr of Employees 159
Free-Float 46,4%
Chart BIOFRONTERA AG
Duration : Period :
Biofrontera AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIOFRONTERA AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 1,35 €
Average target price 4,60 €
Spread / Average Target 241%
EPS Revisions
Managers and Directors
Ludwig Lutter Chief Financial Officer
Wilhelm Konrad Zours Chairman-Supervisory Board
Franca Ruhwedel Member-Supervisory Board
Heikki Lanckriet Member-Supervisory Board
Helge Lubenow Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
BIOFRONTERA AG-8.78%83
CSL LIMITED-11.13%88 334
WUXI BIOLOGICS (CAYMAN) INC.-13.88%46 306
SAMSUNG BIOLOGICS CO.,LTD.-16.17%43 094
ALEXION PHARMACEUTICALS, INC.0.00%40 336
BIOGEN INC.-7.34%32 656